136 related articles for article (PubMed ID: 26419692)
21. Neutrophilic eccrine hidradenitis induced by cytarabine.
Grahovac M; Maximiliane Ehmann L; Flaig M; Reibke R; Wollenberg A
Acta Dermatovenerol Croat; 2012; 20(4):272-5. PubMed ID: 23317491
[No Abstract] [Full Text] [Related]
22. A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia.
Fukushima T; Urasaki Y; Yamaguchi M; Ueda M; Morinaga K; Haba T; Sugiyama T; Nakao S; Origasa H; Umehara H; Ueda T
Anticancer Res; 2012 Feb; 32(2):643-7. PubMed ID: 22287757
[TBL] [Abstract][Full Text] [Related]
23. [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
Miyawaki S; Mizoguchi H; Tomonaga M; Kanamaru A; Tsukagoshi S; Nakamura T; Ohashi Y; Yoshida S; Ohno R
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2229-42. PubMed ID: 9881080
[TBL] [Abstract][Full Text] [Related]
24. High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?
Wolach O; Itchaki G; Bar-Natan M; Yeshurun M; Ram R; Herscovici C; Shpilberg O; Douer D; Tallman MS; Raanani P
Hematol Oncol; 2016 Mar; 34(1):28-35. PubMed ID: 25689584
[TBL] [Abstract][Full Text] [Related]
25. ARA-C RELATED RED EAR SYNDROME.
Sahu KK; Yanamandra U; Malhotra P
Ear Nose Throat J; 2019 Mar; 98(3):169-170. PubMed ID: 30836786
[No Abstract] [Full Text] [Related]
26. [Cytarabine-induced pericarditis].
Yamada T; Tsurumi H; Hara T; Sawada M; Oyama M; Moriwaki H
Rinsho Ketsueki; 1998 Nov; 39(11):1115-20. PubMed ID: 9866424
[TBL] [Abstract][Full Text] [Related]
27. Cytarabine syndrome revisited.
Chng WJ
Br J Haematol; 2003 Sep; 122(6):875. PubMed ID: 12956755
[No Abstract] [Full Text] [Related]
28. Cytarabine ears - A side effect of cytarabine therapy.
Doval D; Kumar Sharma S; Kumar M; Khandelwal V; Choudhary D
J Oncol Pharm Pract; 2020 Mar; 26(2):471-473. PubMed ID: 31117913
[TBL] [Abstract][Full Text] [Related]
29. Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl.
Fort JA; Smith LD
Ann Pharmacother; 1999 May; 33(5):576-8. PubMed ID: 10369621
[TBL] [Abstract][Full Text] [Related]
30. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
Patton T; Zirwas M; Nieland-Fisher N; Jukic D
J Drugs Dermatol; 2004; 3(5):565-6. PubMed ID: 15552612
[TBL] [Abstract][Full Text] [Related]
31. Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia.
Fedele PL; Avery S; Patil S; Spencer A; Haas M; Wei A
Intern Med J; 2014 Aug; 44(8):757-63. PubMed ID: 24863325
[TBL] [Abstract][Full Text] [Related]
32. Cytarabine-induced fever complicating the clinical course of leukemia.
Gonen C; Celik I; Cetinkaya YS; Haznedaroglu I
Anticancer Drugs; 2005 Jan; 16(1):59-62. PubMed ID: 15613905
[TBL] [Abstract][Full Text] [Related]
33. High Dose Cytosine Arabinoside in the consolidation of adult acute myeloid leukemia.
Rahman MH; Khan MA; Islam MS; Afrose S; Ara T
Mymensingh Med J; 2012 Apr; 21(2):213-9. PubMed ID: 22561761
[TBL] [Abstract][Full Text] [Related]
34. Cytarabine-induced lung injury: case report.
Kopterides P; Lignos M; Mentzelopoulos S; Armaganidis A; Pappa V
Anticancer Drugs; 2005 Aug; 16(7):743-5. PubMed ID: 16027523
[TBL] [Abstract][Full Text] [Related]
35. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
Pellier I; Leboucher B; Rachieru P; Ifrah N; Rialland X
J Pediatr Hematol Oncol; 2006 Dec; 28(12):837-9. PubMed ID: 17164656
[TBL] [Abstract][Full Text] [Related]
36. Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report.
Yang X; Liu W; Lyons A; Song Z; Zhai S; Hu K
Eur J Clin Pharmacol; 2018 Feb; 74(2):181-182. PubMed ID: 29080058
[TBL] [Abstract][Full Text] [Related]
37. Miliaria-rash after neutropenic fever and induction chemotherapy for acute myelogenous leukemia.
Nguyen TA; Ortega-Loayza AG; Stevens MP
An Bras Dermatol; 2011; 86(4 Suppl 1):S104-6. PubMed ID: 22068785
[TBL] [Abstract][Full Text] [Related]
38. Dorsolateral midbrain MRI abnormalities and ocular motor deficits following cytarabine-based chemotherapy for acute myelogenous leukemia.
Doan T; Lacayo N; Fisher PG; Liao YJ
J Neuroophthalmol; 2011 Mar; 31(1):52-3. PubMed ID: 20881617
[No Abstract] [Full Text] [Related]
39. [Superior sagittal sinus thrombosis after intrathecal chemotherapy and intravenous high-dose cytarabine in an acute myeloid leukemia case with t(8;21)(q22;q22)].
Kawakami K; Ito R; Kageyama Y; Nagaharu K; Yamaguchi T; Ito N
Rinsho Ketsueki; 2016 Apr; 57(4):477-82. PubMed ID: 27169454
[TBL] [Abstract][Full Text] [Related]
40. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
